This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Segal BH, Bow EJ, Menichetti F . Fungal infections in nontransplant patients with hematologic malignancies. Infect Dis Clin North Am 2002; 16: 935–964.
Krcmery V, Krupova I, Denning DW . Invasive yeast infections other than Candida spp. in acute leukaemia. J Hosp Infect 1999; 41: 181–194.
Canuto MM, Rodero FG . Antifungal drug resistance to azoles and polyenes. Lancet Infect Dis 2002; 9: 550–563.
Ullmann AJ . Review of the safety, tolerability and drug interactions of the new antifungal agents caspofungin and voriconazole. Curr Med Res Opin 2003; 19: 263–271.
Onishi J, Meinz M, Thompson J et al. Discovery of novel antifungal 1,3-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother 2000; 44: 368–377.
Bachman SP, Patterson TF, Lopez-Rilot JL . In vitro activity of caspofungin (MK –0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance. J Clin Microbiol 2002; 40: 2228–2230.
McGee WT, Tereso GJ . Successful treatment of Candida krusei infection with caspofungin acetate, a new antifungal agent. Crit Care Med 2003; 31: 1577–1578.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fanci, R., Guidi, S., Bonolis, M. et al. Candida krusei fungemia in an unrelated allogeneic hematopoietic stem cell transplant patient successfully treated with Caspofungin. Bone Marrow Transplant 35, 1215–1216 (2005). https://doi.org/10.1038/sj.bmt.1704976
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704976